{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:05:33Z","timestamp":1786651533935,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ashjournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Hypertension"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jash.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T02:02:08Z","timestamp":1500516128000},"page":"598-603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Celastrol synergizes with oral nifedipine to attenuate hypertension in preeclampsia: a randomized, placebo-controlled, and double blinded trial"],"prefix":"10.1016","volume":"11","author":[{"given":"Sha","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jash.2017.07.004_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejogrb.2015.02.002","article-title":"Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial","volume":"189","author":"Bijvank","year":"2015","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jash.2017.07.004_bib2","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"2","author":"Abalos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jash.2017.07.004_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1701-2163(16)32776-1","article-title":"Hypertension Guideline Committee; Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars, Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy","volume":"30","author":"Magee","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jash.2017.07.004_bib4","first-page":"970","article-title":"Hemodynamic changes associated with intravenous infusion of the calcium antagonist verapamil in the treatment of severe gestational proteinuric hypertension","volume":"75","author":"Belfort","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jash.2017.07.004_bib5","first-page":"331","article-title":"Nifedipine in the treatment of severe preeclampsia","volume":"77","author":"Fenakel","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jash.2017.07.004_bib6","first-page":"CD001449","article-title":"Drugs for treatment of very high blood pressure during pregnancy","volume":"7","author":"Duley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jash.2017.07.004_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00404-012-2371-x","article-title":"Nifedipine versus labetalol in the treatment of hypertensive disorders of pregnancy","volume":"286","author":"Giannubilo","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jash.2017.07.004_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.semperi.2015.08.011","article-title":"A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy","volume":"39","author":"Clark","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.jash.2017.07.004_bib9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00006250-199404000-00024","article-title":"Nifedipine and its indications in obstetrics and gynecology","volume":"83","author":"Childress","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jash.2017.07.004_bib10","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-105-5-714","article-title":"Nifedipine in myocardial ischemia, systemic hypertension, and other cardiovascular disorders","volume":"105","author":"Ferlinz","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jash.2017.07.004_bib11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-9378(90)91011-Z","article-title":"The use of nifedipine during the postpartum period in patients with severe preeclampsia","volume":"162","author":"Barton","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jash.2017.07.004_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/ajh.2010.87","article-title":"Celastrol: a new therapeutic potential of traditional Chinese medicine","volume":"23","author":"Morita","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2017.07.004_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2012.04.054","article-title":"Protective effect of celastrol in rat cerebral ischemia model: down-regulating p-JNK, p-c-Jun and NF-kappaB","volume":"1464","author":"Li","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.jash.2017.07.004_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jss.2013.07.048","article-title":"Celastrol protects kidney against ischemia-reperfusion-induced injury in rats","volume":"186","author":"Chu","year":"2014","journal-title":"J Surg Res"},{"key":"10.1016\/j.jash.2017.07.004_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000354770","article-title":"Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation","volume":"131","author":"Ni","year":"2014","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jash.2017.07.004_bib16","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1111\/bph.12838","article-title":"Celastrol protects ischaemic myocardium through a heat shock response with up-regulation of haeme oxygenase-1","volume":"171","author":"Der Sarkissian","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jash.2017.07.004_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12192-014-0536-1","article-title":"Celastrol, an oral heat shock activator, ameliorates multiple animal disease models of cell death","volume":"20","author":"Sharma","year":"2015","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.jash.2017.07.004_bib18","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1159\/000445554","article-title":"Celastrol-Induced Suppression of the MiR-21\/ERK Signalling Pathway Attenuates Cardiac Fibrosis and Dysfunction","volume":"38","author":"Cheng","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jash.2017.07.004_bib19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ajh.2010.75","article-title":"Celastrol attenuates hypertension-induced inflammation and oxidative stress in vascular smooth muscle cells via induction of heme oxygenase-1","volume":"23","author":"Yu","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jash.2017.07.004_bib20","series-title":"Use of celastrol to treat alzheimer's disease","author":"Vigo-Pelfrey","year":"1999"},{"key":"10.1016\/j.jash.2017.07.004_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijcard.2014.10.111","article-title":"Oral nifedipine versus intravenous labetalol for the treatment of severe hypertension in pregnancy","volume":"178","author":"Shi","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jash.2017.07.004_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1479-828X.2000.tb01137.x","article-title":"The detection, investigation and management of hypertension in pregnancy: full consensus statement","volume":"40","author":"Brown","year":"2000","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.jash.2017.07.004_bib23","first-page":"1245","article-title":"Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy","volume":"157","author":"Rey","year":"1997","journal-title":"CMAJ"},{"key":"10.1016\/j.jash.2017.07.004_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1600-0412.2002.810105.x","article-title":"Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia","volume":"81","author":"Aali","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jash.2017.07.004_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jcla.20295","article-title":"Evaluation of metalloproteinases 2 and 9 and their inhibitors in physiologic and pre-eclamptic pregnancy","volume":"23","author":"Montagnana","year":"2009","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.jash.2017.07.004_bib26","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1073\/pnas.1309561110","article-title":"Matrix metalloproteinase-9 deficiency phenocopies features of preeclampsia and intrauterine growth restriction","volume":"110","author":"Plaks","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jash.2017.07.004_bib27","first-page":"325","article-title":"Matrix metalloproteinases as drug targets in preeclampsia","volume":"14","author":"Palei","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jash.2017.07.004_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.01.057","article-title":"Celastrol, an inhibitor of heat shock protein 90beta potently suppresses the expression of matrix metalloproteinases, inducible nitric oxide synthase and cyclooxygenase-2 in primary human osteoarthritic chondrocytes","volume":"708","author":"Ding","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jash.2017.07.004_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000331729","article-title":"Celastrol inhibits\u00a0breast cancer cell invasion via suppression of NF-kB-mediated matrix metalloproteinase-9 expression","volume":"28","author":"Kim","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jash.2017.07.004_bib30","doi-asserted-by":"crossref","first-page":"e68905","DOI":"10.1371\/journal.pone.0068905","article-title":"Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4\/NF-kappaB-mediated matrix metalloproteinase-9 expression","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jash.2017.07.004_bib31","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.intimp.2012.08.016","article-title":"Celastrol inhibits interleukin-17A-stimulated rheumatoid fibroblast-like synoviocyte migration and invasion through suppression of NF-kappaB-mediated matrix metalloproteinase-9 expression","volume":"14","author":"Li","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jash.2017.07.004_bib32","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.2147\/IJN.S117425","article-title":"Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats","volume":"11","author":"Li","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.jash.2017.07.004_bib33","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3892\/or.2014.3535","article-title":"Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9","volume":"32","author":"Mi","year":"2014","journal-title":"Oncol Rep"}],"container-title":["Journal of the American Society of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171117302590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933171117302590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T23:30:17Z","timestamp":1535585417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933171117302590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1933171117302590"],"URL":"https:\/\/doi.org\/10.1016\/j.jash.2017.07.004","relation":{},"ISSN":["1933-1711"],"issn-type":[{"value":"1933-1711","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol synergizes with oral nifedipine to attenuate hypertension in preeclampsia: a randomized, placebo-controlled, and double blinded trial","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jash.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society of Hypertension. All rights reserved.","name":"copyright","label":"Copyright"}]}}